Saturday, December 29, 2012

Industry Self-Regulation - An Update

Yesterday I wrote a post about the plight of Ryan Harrington, the young man who, were it not for a drug called Celontin, would suffer upwards of 200 seizures a day. Because the Harper regime opted for a voluntary system instead of a law requiring companies to report drug shortages, Harrington had only a one-week supply of the drug left.

The Toronto Star today reports that his family has been able to secure a one-month supply of the drug from the U.S., no thanks to our government. Says Brigitte Harrington, Ryan's mother:

“It’s a band-aid” ... “We’ve applied another band-aid to the layer. We have not addressed the problem. We have not cleaned up the mess.”

Despite the shortage, Health Canada denied three separate applications from Harrington to acquire the drug from the U.S.

When asked why the first three requests were denied, Health Canada spokesperson Sara Lauer responded, “Initial requests … were not fulfilled because the manufacturer, ERFA, informed Health Canada the product would be on the market until December 2012 and it was working to avoid any potential back-order.”

I would like to think that our political 'leadership' has learned something from this episode, distressing in its wider implications, but experience suggests that in the battle between marketplace ideology, so beloved of the Harper regime, and the public good, we the people are pretty much on our own.


  1. Isn't that the general philosophy, Lorne? "You're on your own."

  2. It is indeed a Hobbesian state that Mr. harper et al. are cultivating, Owen.